Novel personalized management strategies for fibrosing diseases (FibroPET)

UiO:Life Science funds convergence environments – interdisciplinary research groups that address major challenges within health and environment.

We will identify, develop and test new personalized clinical management strategies for patients with fibrosing diseases to improve outcome and quality of life. Specifically, we will (1) focus on basic research to establish new positron emission tomography (PET) tracers, including their utility in preclinical studies; (2) integrate PET imaging into clinical practice for diagnosis, prognostic and outcome evaluation; (3) conduct a randomized clinical trial applying personalized approaches; (4) integrate a learning design to facilitate timely diagnosis and knowledge-based medical decisions. The proposed interdisciplinary Convergence Environment (CE) will enable highly competitive basic, translational and clinical research, together with research driven innovation and communication strategies, and initiate new clinical trials and translation into clinical use, benefiting patients with fibrosing diseases.

Novel personalized management strategies for fibrosing diseases (FibroPET) - UiO:Life Science

 
Page visits: 186